Horizon Therapeutics PLC (NASDAQ:HZNP)

85.11
Delayed Data
As of Jun 24
 +2.22 / +2.68%
Today’s Change
78.85
Today|||52-Week Range
120.54
-21.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line26.0M89.9M-32.9M-5.1M
 
 
 
 
 
Depreciation69.2M69.0M58.9M59.1M
 
 
 
 
 
Total Other Cash Flow38.1M28.2M39.4M50.1M
 
 
 
 
 
Funds From Operations136.8M121.0M66.9M101.3M
 
 
 
 
 
Funds From/For Other Operating Expenses51.9M12.3M10.8M10.0M
 
 
 
 
 
Net Cash Flow - Operating Activities84.9M108.7M56.2M91.3M
 
 
 
 
 
 
InvestingCapital Expenditures-119.0K-3.9M-1.8M-5.0M
 
 
 
 
 
Fixed Asset Disposal9.4M35.0M0.000.00
 
 
 
Other Investing - Sources0.000.000.006.0M
 
 
Net Cash Flow Investing9.3M31.1M-1.8M991.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00818.0M0.00517.4M
 
 
 
Long Term Debt Reduction-1.0K-818.0M-300.0M-776.3M
 
 
 
 
 
Net Proceeds Stock Sale6.1M11.1M337.8M6.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing3.7M1.6M17.2M7.2M
 
 
 
 
 
Net Cash Flow - Financing2.4M9.5M20.6M-259.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash315.0K-692.0K-518.0K576.0K
 
 
 
 
 
 
Net Change In Cash96.5M149.4M74.9M-167.4M